- Home
- MVST vs AMRN Comparison
MVST vs AMRN Comparison
Compare MVST & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- AMRN
- Stock Information
- Founded
- MVST 2006
- AMRN 1989
- Country
- MVST United States
- AMRN Ireland
- Employees
- MVST N/A
- AMRN N/A
- Industry
- MVST Industrial Machinery/Components
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MVST Miscellaneous
- AMRN Health Care
- Exchange
- MVST Nasdaq
- AMRN Nasdaq
- Market Cap
- MVST 1.3B
- AMRN 216.0M
- IPO Year
- MVST N/A
- AMRN 1993
- Fundamental
- Price
- MVST $3.61
- AMRN $16.40
- Analyst Decision
- MVST Strong Buy
- AMRN Strong Sell
- Analyst Count
- MVST 1
- AMRN 1
- Target Price
- MVST $3.00
- AMRN $12.00
- AVG Volume (30 Days)
- MVST 9.2M
- AMRN 185.3K
- Earning Date
- MVST 08-07-2025
- AMRN 07-30-2025
- Dividend Yield
- MVST N/A
- AMRN N/A
- EPS Growth
- MVST N/A
- AMRN N/A
- EPS
- MVST N/A
- AMRN N/A
- Revenue
- MVST $414,941,000.00
- AMRN $214,112,000.00
- Revenue This Year
- MVST $26.08
- AMRN N/A
- Revenue Next Year
- MVST $29.71
- AMRN $7.88
- P/E Ratio
- MVST N/A
- AMRN N/A
- Revenue Growth
- MVST 21.68
- AMRN N/A
- 52 Week Low
- MVST $0.15
- AMRN $7.08
- 52 Week High
- MVST $4.72
- AMRN $17.18
- Technical
- Relative Strength Index (RSI)
- MVST 48.33
- AMRN 72.83
- Support Level
- MVST $3.42
- AMRN $15.78
- Resistance Level
- MVST $4.27
- AMRN $17.18
- Average True Range (ATR)
- MVST 0.32
- AMRN 0.96
- MACD
- MVST -0.11
- AMRN 0.21
- Stochastic Oscillator
- MVST 17.69
- AMRN 86.99
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.